An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a in severe COVID-19: The COVIFERON II randomized controlled trial

INTRODUCTION: Coronavirus disease 2019 (COVID-19) has been a serious obstacle in front of public health. Interferon-beta 1a (IFN-β 1a) has been used to treat patients with COVID-19. We aimed to compare the effectiveness of high-dose IFN-β 1a compared to low dose IFN-β 1a in severe COVID-19 cases. ME...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int Immunopharmacol
Main Authors: Alavi Darazam, Ilad, Hatami, Firouze, Mahdi Rabiei, Mohammad, Amin Pourhoseingholi, Mohamad, Shabani, Minoosh, Shokouhi, Shervin, Mardani, Masoud, Moradi, Omid, Javandoust Gharehbagh, Farid, Mirtalaee, Nasrinsadat, Negahban, Halimeh, Amirdosara, Mahdi, Zangi, Masoud, Hajiesmaeili, Mohammadreza, Kazempour, Muhanna, Shafigh, Navid
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier B.V. 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8238656/
https://ncbi.nlm.nih.gov/pubmed/34224994
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.intimp.2021.107916
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados